ADMA Biologics's market cap is currently $3.74B. The company's EPS TTM is $0.147; its P/E ratio is 18.44; ADMA Biologics is scheduled to report earnings on August 6, 2025, and the estimated EPS forecast is $0.15. See an overview of income statement, balance sheet, and cash flow financials.
